Dzmitry Skazau/iStock via Getty ImagesArcutis Biotherapeutics (NASDAQ:ARQT) rose 12% amid some takeover speculation. The biotech is speculated to have attracted…
Investing.com’s Fair Value analysis has once again demonstrated its effectiveness in identifying undervalued opportunities, with Arcutis Biotherapeutics (NASDAQ:) delivering a…
